
    
      This study is a pilot study as part of planning for a larger randomized controlled trial. The
      study plans to enroll a total of 30 patients, with 10 patients randomly assigned in each
      group of the study. Group I will receive the standard of care multimodal pharmacological
      management. Group II will receive standard of care multimodal pharmacological management plus
      the Quadratus Lumborum II local anesthetic block. Group III will receive standard of care
      multimodal pharmacological management plus the Quadratus Lumborum III local anesthetic block.
      Measurements of opioid use, pain, and side effects will be recorded for each patient.
    
  